This text of Georgia § 26-3-10 (Selling, delivering, or giving away of new drugs; exemptions) is published on Counsel Stack Legal Research, covering Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
(a)No person shall sell, deliver, offer for sale, hold for sale, or give away any new drug unless:
(1)An application with respect thereto has become effective under Section 505 of the federal act; or (2) When not subject to the federal act unless such drug has been tested and has not been found to be unsafe for use under the conditions prescribed, recommended, or suggested in the labeling thereof and prior to selling or offering such drug for sale, there has been filed with the State Board of Pharmacy an application setting forth:
(A)Full reports of investigations which have been made to show whether or not such drug is safe for use;
(B)A full list of the articles used as components of such drug;
(C)A full statement of the composition of such drug;
(D)A full description of the method
Free access — add to your briefcase to read the full text and ask questions with AI
(a) No person shall sell, deliver, offer for sale, hold for sale, or give away any new drug unless: (1) An application with respect thereto has become effective under Section 505 of the federal act; or (2) When not subject to the federal act unless such drug has been tested and has not been found to be unsafe for use under the conditions prescribed, recommended, or suggested in the labeling thereof and prior to selling or offering such drug for sale, there has been filed with the State Board of Pharmacy an application setting forth: (A) Full reports of investigations which have been made to show whether or not such drug is safe for use; (B) A full list of the articles used as components of such drug; (C) A full statement of the composition of such drug; (D) A full description of the methods used in and the facilities and controls used for the manufacture, processing, and packing of such drug; (E) Such samples of such drug and of the articles used as components thereof as the State Board of Pharmacy may require; and (F) Specimens of the labeling proposed to be used for such drug. (b) An application provided for in paragraph (2) of subsection (a) of this Code section shall become effective 60 days after the filing thereof, except that if the State Board of Pharmacy finds after due notice to the applicant and after giving him an opportunity for a hearing that the drug is not safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof, he shall prior to the effective date of the application issue an order refusing to permit the application to become effective. (c) This Code section shall not apply: (1) To a drug intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety in drugs, provided the drug is plainly labeled "For investigational use only"; or (2) To a drug sold in the state at any time prior to the enactment of this chapter or introduced into interstate commerce at any time prior to the enactment of the federal act; or (3) To any drug manufactured, labeled, and sold for veterinary purposes. (d) An order refusing to permit an application under this Code section to become effective may be revoked by the State Board of Pharmacy.